RSS

pregabalin

Partner and patent attorney at intellectual property firm, Withers & Rogers, Dr Nicholas Jones, discusses why drug companies should continue to pursue new medical patents in the future, despite recent examples of legal disputes. Read more

Opinion

Researchers from the University of Oxford in collaboration with an intellectual property law firm have revealed that the NHS may be able to recoup over half a billion pounds from Pfizer if its Supreme Court patent appeal is unsuccessful Read more

News

The UK Bioindustry Association (BIA) has been allowed to intervene in a Supreme Court case, reviewing Warner-Lambert Company LLC v Generics (UK) Ltd and Actavis. Read more

News

Pfizer has offered to refund practices for the cost of switching prescriptions of pregabalin over to the brand name as part of an ongoing legal action over the patent of the drug Read more

News